Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chronic Convection Enhanced Delivery of Topotecan for Recurrent Malignant Glioma

NCT06666712 is registered in ClinicalTrials.gov with Jeffrey N. Bruce as lead sponsor.

NCT NCT06666712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06666712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chronic Convection Enhanced Delivery of Topotecan for Recurrent Malignant Glioma
Lead sponsor
Jeffrey N. Bruce
Phase
Phase 1
Overall status
Recruiting
Start date
June 12, 2026
Completion date
January 31, 2028
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, recurrent, idh1/idh2 mutation, malignant glioma (who grade iii or iv)